The Fundamental Disconnect Between Pharma and Technology

Article

Pharmaceutical Executive

Otsuka Pharmaceutical’s President and CEO of Development and Commercialization William Carson explains the initial growing pains the company went through with their technology company partner in the early development stages of the first U.S. FDA approved digital medicine system.

Otsuka Pharmaceutical’s President and CEO of Development and Commercialization William Carson explains the initial growing pains the company went through with their technology company partner in the early development stages of the first U.S. FDA approved digital medicine system, Abilify Mycite.

His interview was recorded during the May 2018 Financial Times Live ‘s US Healthcare & Life Sciences Summit in New York City.

 

 

Recent Videos
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Kimberley Chiang, CoverMyMeds
Most Effective Strategies to Close the Innovation Gap in Women’s Health
Root Causes of Innovation Gap in Women’s Health
Fred Aslan
Gameto - Addressing Regulatory Hurdles in iPSC-Based Fertility
Fred Aslan
Related Content
Don Sortor

Protecting the Pipeline: Secure Communications Strategies to Thwart Espionage and Safeguard Sensitive Information and Intellectual Property

Don Sortor
March 18th 2025
Article

In an era where business-critical information is exchanged instantly, unsecured communication channels are a significant risk.

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

Miranda Schmalfuhs
February 10th 2025
Podcast

Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence.

Foster and Markovitz

Pre-Launch Prep for Emerging Biopharmas: Data First, Then the Rest

Todd Foster;Yair Markovits
March 13th 2025
Article

Making early commercial data and analytics decisions for launch cen future-proof their data management.

AI-Enabled Benchmarking: Transforming Performance Measurement for Pharma Brands

AI-Enabled Benchmarking: Transforming Performance Measurement for Pharma Brands

John Clarke
March 12th 2025
Article

Market dynamics boost the need and urgency for more sophisticated benchmarking strategies.

Scott Snyder

Trends Shaping Direct to Patient in Pharma: Q&A with Scott Snyder

Mike Hollan
March 12th 2025
Article

EVERSANA’s chief digital officer discusses recent developments in the pharma industry that are impacting its relationship with patients and new technology.

The Virtual Reality of Modern Pharma Sales and Marketing

The Virtual Reality of Modern Pharma Sales and Marketing

Mike Hollan
March 11th 2025
Article

Heather Gervais, CEO of Osso VR, discusses how technological advancements in VR are solving problems for pharmaceutical sales reps.